
The FDA is currently developing what they term “Risk Evaluation and Mitigation Strategies” or REMS in relation to opioid pain medications. What that means is they are working on a plan to ensure that the benefits of opioid medications outweigh the risks, which include misuse, abuse and accidental overdose.
It's no secret that the abuse of prescription drugs has increased dramatically over the past several years. The FDA is developing REMS in an effort to curb that abuse. But it's up...
Opioid medications have a natural property that causes physical dependence. Other medications used... Read more »
...charged with 50 counts of unlawfully prescribing opioid pain medication. In 2004 Dr. Hurwitz... Read more »
...treatment of persistent pain usually requires long-acting opioids, and it may be necessary to... Read more »
...treatment of chronic pain involves long-term narcotic (opioid) treatment. However, as has been... Read more »
...considered an infraction of your pain care agreement or "opioid contract"; you might have been... Read more »
The Food and Drug Administration has granted approval for a new opioid pain medication, Opana (oxymorphone hydrochloride). The medication will be... Read summary »
An experimental 'double' opioid pain medication has moved into Phase III clinical trials. The med, currently called Q8003IR, is an immediate-release... Read summary »
Seriously ill patients who take opioid pain medications often face constipation. But the drug methylnaltrexone appears to provide relief from this... Read summary »
U.S. researchers report that moderate, long-term use of opioid pain medications such as morphine don't impair a person's driving ability. In a recent... Read summary »
The U.S. Food and Drug Administration (FDA) has approved a new opioid painkiller called Onsolis for patients with severe cancer-related pain.... Read summary »